Share-Based Expense |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compensation Related Costs [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Expense |
Total share-based expense related to stock options was approximately $11,000 and $19,000 during each of the three months ended March 31, 2026 and 2025, respectively.
Share-based expense is classified in the condensed consolidated statements of operations as follows:
Employee Stock Options
No employee stock option awards to purchase shares of common stock were granted or exercised during the three months ended March 31, 2026 and 2025. During the three months ended March 31, 2026 and 2025, options to purchase shares of common stock and shares of common stock expired, respectively. The Company recognized a total of approximately $ and $ of share-based expense related to employee stock options during each of the three months ended March 31, 2026 and 2025.
Non-Employee Stock Options
There were non-employee options outstanding as of both March 31, 2026 and December 31, 2025. There were non-employee stock options granted or exercised during the three months ended March 31, 2026 and 2025. No non-employee stock option grants expired during the three months ended March 31, 2026 and 2025. The Company did t recognize any share-based expense related to non-employee stock options during the three months ended March 31, 2026 and 2025. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||